Northern Survey on Therapeutic Oxygen Prescription
NONSTOP
1 other identifier
observational
500
1 country
2
Brief Summary
This is a prospective multicenter observational trial. Included patients and attending physician complete a standardized questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2019
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2019
CompletedFirst Posted
Study publicly available on registry
May 6, 2019
CompletedStudy Start
First participant enrolled
July 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2021
CompletedAugust 7, 2019
August 1, 2019
2 years
May 2, 2019
August 6, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Validation of indication of Long-term Oxygen therapy (LTOT)
Aim of this study is to observe the real-world handling with longterm Oxygen treatment in northern Germany
12 month
Interventions
This is a prospective multicenter observational trial. Included patients and attending physician complete a standardised questionnaire.
Eligibility Criteria
Patients fulfilling the Inclusion criteria and not the exclusion criteria at 3 Centers in nothern Germany
You may qualify if:
- Patients with chronic lung disease, age \> 18 years
- Established domiciliary LTOT \> 4 weeks
- Scheduled for control of oxygen therapy with arterial/capillary
You may not qualify if:
- No informed consent
- Pulmonary exacerbation within the last 2 weeks
- Signs of heart failure (edema, congestion)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Dep. Respiratory Medicine, Hannover Medical School
Hanover, 30625, Germany
Department of Respiratory Medicine, Medizinische Hochschule Hannover
Hanover, 30625, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Jens Gottlieb, Prof. Dr. med.
Hannover Medical School
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2019
First Posted
May 6, 2019
Study Start
July 2, 2019
Primary Completion
June 20, 2021
Study Completion
September 20, 2021
Last Updated
August 7, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share
No sharing of individual participants data